Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial

Autor: Peter Junker, Tove Lorenzen, Tonny Jensen, Mikkel Østergaard, Natalia Manilo, Henning Bliddal, Kristian Stengaard-Pedersen, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Marcin Ryszard Kowalski, Hans Christian Horn, Hanne Merete Lindegaard, I. Hansen, Ole Slot, Anette Jørgensen, Inger Lauge Johansen, Palle Ahlquist, Asta Linauskas, Annette Schlemmer, Lars Kjær Nielsen, Torkell Ellingsen, Peter Mosborg Pedersen, O Majgaard, Christian Gytz Ammitzbøll, Mette Yde Dam, Johnny Lillelund Raun, Merete Lund Hetland, Kim Hørslev-Petersen, Henrik Skjødt, Sophine B. Krintel

Publikováno v: Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N, Bliddal, H & OPERA Study Group 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1

This study aims to investigate 1-year hand bone loss (HBL 1-year) in early rheumatoid arthritis (RA) patients treated with a methotrexate (MTX) and intra-articular triamcinolone treat-to-target strategy +/− adalimumab and to determine if HBL 6month

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1278219bd037cb38835e551f2c6113
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4

Effect of Percutaneous Ethanol Injection TherapyVersusSuppressive Doses ofl-Thyroxine on Benign Solitary Solid Cold Thyroid Nodules: A Randomized Trial1

Autor: Finn Noe Bennedbæk, Lars Kjær Nielsen, Laszlo Hegedüs

Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 83:830-835

The results of studies using suppressive doses of l-T4 on benign solitary solid cold thyroid nodules have been conflicting. Recently, intranodular injection of absolute ethanol has been proposed as an effective treatment, but has been evaluated only

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf24785ee09a6345bf10cdea7aa60212
https://doi.org/10.1210/jcem.83.3.4673